Announcements



We are pleased to announce the expanded role of McDavid Dandan as Regional Lead – Supply Chain Management w.e.f. 1st May, 2025.
- Effective from 1st May 2025.
We are pleased to announce that McDavid Dandan will take on an expanded role as Regional Lead for Supply Chain Management handling Philippines, Singapore, and Malaysia.
Read More
Appointments, HQ Singapore

1st May 2025
We are pleased to announce the appointment of Dr. Hanadi Setiarto as Country Group Head for Wellesta Indonesia w.e.f. 1st October 2024.
- Effective from: 1st Oct 2024
We are pleased to announce the appointment of Dr. Hanadi Setiarto as Country Group Head for Wellesta Indonesia. Before joining Wellesta, Dr. Hanadi was President Director of PT ACTAVIS Indonesia, a TEVA PHARMACEUTICAL subsidiary. He is a seasoned commercial leader with 32 years of experience within the pharmaceutical industry.
Read More
Appointments, Indonesia

26 Sept 2024
We are pleased to announce the appointment of Mr. Yohannes Sinaga as Country Manager, PT Wellesta CPI Indonesia.
- Effective from 1st May 2020
Mr. Yohannes Sinaga has been appointed as the Country Manager for PT Wellesta CPI Indonesia, effective from 1st May 2020. His last position was Chief Marketing Officer for AstraZeneca Indonesia. He has extensive experience with 15 years in pharmaceutical industry.
Read More
Announcement, Indonesia

18th May 2021
We are pleased to announce the appointment of Mr. Slamet Achmad as Product Manager for PT. Wellesta CPI.
- Effective from 1st Dec 2019
Mr. Slamet Achmad has been appointed as Product Manager for PT. Wellesta CPI Indonesia, effective from 1th December 2019. Mr. Slamet started his career at PT Dumex Indonesia as Medical Representative in 1992. In 1997, he then transited to a Medical Representative in PT Pfizer Indonesia. He was promoted to District Sales Manager in 2002 and Product Manager in 2005. In 2015, he joined PT Citra Pharma Indonesia as Product Manager.
Read More
Announcement, Indonesia

18th May 2021
We are pleased to announce partnership in Indonesia by acquiring majority of shares & management control of PT Citra Pharma Indonesia.
- Effective from 1st Dec 2019
We are very pleased to announce our partnership in Indonesia by acquiring majority of shares & management control of PT Citra Pharma Indonesia from current shareholders. It will now operate under the new name PT Wellesta CPI Healthcare and will be based from Jakarta. PT Citra Pharma Indonesia is in successful operations for last 12-years and have been partner with MNC players in Pharma and Healthcare sector in the Indonesian market.
Read More
Announcement, Indonesia

18th May 2021
Announcements



Dengan senang hati kami menginformasikan penunjukan Bapak Yohannes Sinaga sebagai Country Manager di PT Wellesta CPI Indonesia.
Mulai tanggal 1 Mei 2020.
Wellesta Holding, dengan senang hati mengumumkan penunjukkan Bpk Yohannes Sinaga (Mr Joe) sebagai Country Manager PT Wellesta CPI Indonesia, efektif per 1 Mei 2020. Posisi terakhir Mr Joe adalah sebagai Chief Marketing Officer di AstraZeneca Indonesia. Beliau memiliki pengalaman yang luas dengan lebih dari 15 tahun bekecimpung di bidang industry farmasi.
Read More
Announcement, Indonesia

18th May 2021
Bersama ini kami umumkan bergabungnya Slamet Achmad sebagai Product Manager di PT Wellesta CPI
- Efektif mulai 1 Desember 2019.
Slamet memulai karirnya di PT Dumex Indonesia sebagai Medical Representative pada tahun 1992 dan bergabung di PT Pfizer Indonesia sebagai Medical Representative pada tahun 1997. Dia mendapatkan promosi menjadi District Sales Manager di tahun 2002 dan Product Manager di tahun 2005. Slamet mulai bergabung di PT Citra Pharma Indonesia sebagai Product Manager sejak tahun 2015.
Read More
Announcement, Indonesia

18th May 2021
Kami dengan senang hati mengumumkan kemitraan di Indonesia dengan mengakuisisi mayoritas saham & kontrol manajemen PT Citra Pharma Indonesia.
- Diakuisisi sejak tanggal 1 Desember 2019.
Kami sangat senang hati mengumumkan kemitraan kami di Indonesia dengan mengakuisisi mayoritas saham & kontrol manajemen PT Citra Pharma Indonesia dari pemegang saham saat ini. Sekarang akan beroperasi dengan nama baru PT Wellesta CPI Healthcare dan akan berbasis dari Jakarta. PT Citra Pharma Indonesia telah beroperasi selama 12 tahun terakhir dan telah bermitra dengan para pemain MNC di sektor Farmasi dan Kesehatan di pasar Indonesia. PT Citra Pharma menyediakan layanan penjualan & pemasaran medis kepada MNC di Indonesia dengan rekam jejak yang sukses dan mengutamakan kepatuhan.
Read More
Announcement, Indonesia

18th May 2021